← TrialMatch
HomeTrials

Regulating Together in Tuberous Sclerosis Complex

The purpose of this study is to use a program called Regulating Together (RT), a remote, non-pharmacologic intervention to treat symptoms of emotion dysregulation in children and adolescents with Tuberous Sclerosis Complex (TSC) and TSC-Associated Neuropsychiatric Disorder (TAND).

Condition(s)TSC, Behavioral Symptoms
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe purpose of this study is to use a program called Regulating Together (RT), a remote, non-pharmacologic intervention to treat symptoms of emotion dysregulation in children and adolescents with Tuberous Sclerosis Complex (TSC) and TSC-Associated Neuropsychiatric Disorder (TAND).
Who can participateInclusion Criteria: * Children ages 8-17 years inclusive with a documented clinical and/or genetic diagnosis of TSC and exhibiting symptoms of behavioral dysregulation (identified on the TAND Checklist having temper tantrums, aggressive outbursts, self-injury, and/or impulsivity) are eligible for inclusion. Additional inclusion/eligibility criteria include: * Participants and their caregivers have access to a computer, phone, or tablet with video capability and stable internet connection. If lack of a device or internet service is the sole barrier to eligibility/participation, interested individuals will be connected to a TSC Clinic social worker to link them to existing government and charity programs specifically addressing this disparity in underserved communities and households in need
Ages8 Years to 17 Years
SexAll
Lead sponsorChildren's Hospital Medical Center, Cincinnati
LocationsCarrboro, North Carolina, United States; Cincinnati, Ohio, United States
Start date2023-12-20
NCT IDNCT06105736
Official listinghttps://clinicaltrials.gov/study/NCT06105736

🔍 Search all trials →